Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

at a significantly lower cost — around $250 to $350 per month for tirzepatide, compared to Zepbound's list price of $1,059. With the official shortage over, the FDA has signaled it will crack ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

People can get prescriptions through telehealth, and the cost is lower than traditional prescriptions not covered by insurance. Weight loss drugs that use tirzepatide as the active ingredient cost ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...

Cheaper versions of the drug, known as compounded tirzepatide, might be restricted in 2025. Patients could face higher costs and tougher access, and telehealth is racing to adapt. The FDA has ...

Weight loss efficacy: While both medications are highly effective for weight loss, studies suggest tirzepatide may lead to greater reductions in body weight due to its dual-action mechanism. Cost ...